Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Japanese researchers develop antimalarial agents

Nov. 17, 2016

Daewoong Pharmaceutical describes ATPase inhibitors and/or 5-HT2A and/or M1 and/or M2 antagonists

Nov. 17, 2016

Concert Pharmaceuticals discloses OTX-015 analogues

Nov. 17, 2016

Tianjin Institute of Pharmaceutical Research patents URAT1 inhibitors

Nov. 17, 2016

Medshine Discovery presents EGFR inhibitors

Nov. 16, 2016

Bayer Pharma develops t-PA inhibitors

Nov. 16, 2016

H. Lundbeck describes PDE1 inhibitors

Nov. 16, 2016

ImmunoMet Therapeutics discloses OXPHOX inhibitors

Nov. 16, 2016

Arena Pharmaceuticals patents 5-HT2C receptor agonists

Nov. 16, 2016

Vallaurix presents MC1 receptor agonists

Nov. 15, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...